tradingkey.logo

Inspire Medical Systems Inc

INSP

131.165USD

+5.065+4.02%
Market hours ETQuotes delayed by 15 min
3.87BMarket Cap
58.12P/E TTM

Inspire Medical Systems Inc

131.165

+5.065+4.02%
More Details of Inspire Medical Systems Inc Company
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Company Info
Ticker SymbolINSP
Company nameInspire Medical Systems Inc
IPO dateMay 03, 2018
CEOMr. Timothy P. (Tim) Herbert
Number of employees1246
Security typeOrdinary Share
Fiscal year-endMay 03
Address5500 Wayzata Blvd Ste 1600
CityGOLDEN VALLEY
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code55416-1237
Phone17639575037
Websitehttps://www.inspiresleep.com/
Ticker SymbolINSP
IPO dateMay 03, 2018
CEOMr. Timothy P. (Tim) Herbert
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Timothy P. (Tim) Herbert
Mr. Timothy P. (Tim) Herbert
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
77.13K
-79.27%
Mr. Shawn T. Mccormick
Mr. Shawn T. Mccormick
Independent Director
Independent Director
31.05K
+14.79%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
23.01K
+0.58%
Mr. Bryan K. Phillips, J.D.
Mr. Bryan K. Phillips, J.D.
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
6.36K
-43.33%
Mr. Jason P. Kelly
Mr. Jason P. Kelly
Chief Manufacturing and Quality Officer
Chief Manufacturing and Quality Officer
4.54K
--
Ms. Shelley G. Broader
Ms. Shelley G. Broader
Independent Director
Independent Director
4.12K
+3.72%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
3.37K
+60.29%
Mr. John C. Rondoni
Mr. John C. Rondoni
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Carlton W. Weatherby
Mr. Carlton W. Weatherby
Chief Strategy and Growth Officer
Chief Strategy and Growth Officer
--
--
Ms. Georgia Garinoismelenikiotou
Ms. Georgia Garinoismelenikiotou
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Timothy P. (Tim) Herbert
Mr. Timothy P. (Tim) Herbert
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
77.13K
-79.27%
Mr. Shawn T. Mccormick
Mr. Shawn T. Mccormick
Independent Director
Independent Director
31.05K
+14.79%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
23.01K
+0.58%
Mr. Bryan K. Phillips, J.D.
Mr. Bryan K. Phillips, J.D.
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
6.36K
-43.33%
Mr. Jason P. Kelly
Mr. Jason P. Kelly
Chief Manufacturing and Quality Officer
Chief Manufacturing and Quality Officer
4.54K
--
Ms. Shelley G. Broader
Ms. Shelley G. Broader
Independent Director
Independent Director
4.12K
+3.72%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
United States
193.61M
96.17%
All other countries
7.71M
3.83%
By Business
By Region
No Data
Shareholding Stats
Updated: Tue, May 20
Updated: Tue, May 20
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
12.20%
The Vanguard Group, Inc.
10.91%
Fidelity Management & Research Company LLC
6.86%
Wasatch Global Investors Inc
5.17%
Dragoneer Investment Group, LLC
4.40%
Other
60.46%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
12.20%
The Vanguard Group, Inc.
10.91%
Fidelity Management & Research Company LLC
6.86%
Wasatch Global Investors Inc
5.17%
Dragoneer Investment Group, LLC
4.40%
Other
60.46%
Shareholder Types
Shareholders
Proportion
Investment Advisor
66.57%
Investment Advisor/Hedge Fund
34.59%
Hedge Fund
6.84%
Private Equity
4.40%
Pension Fund
2.68%
Research Firm
2.40%
Individual Investor
1.24%
Bank and Trust
0.83%
Venture Capital
0.30%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
879
35.51M
120.38%
-5.57M
2025Q1
912
35.71M
121.08%
-5.66M
2024Q4
874
35.22M
118.69%
-4.72M
2024Q3
852
35.48M
118.45%
-2.86M
2024Q2
825
33.60M
112.73%
-2.85M
2024Q1
801
33.20M
111.87%
-2.01M
2023Q4
786
32.35M
109.45%
+751.92K
2023Q3
753
29.93M
101.80%
-635.63K
2023Q2
727
29.57M
101.94%
-987.85K
2023Q1
680
29.78M
102.13%
-573.41K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
3.60M
12.2%
-96.27K
-2.61%
Mar 31, 2025
The Vanguard Group, Inc.
3.22M
10.91%
-44.71K
-1.37%
Mar 31, 2025
Fidelity Management & Research Company LLC
2.02M
6.86%
-48.18K
-2.33%
Mar 31, 2025
Wasatch Global Investors Inc
1.52M
5.17%
+202.34K
+15.31%
Mar 31, 2025
Dragoneer Investment Group, LLC
1.30M
4.4%
+426.49K
+48.96%
Mar 31, 2025
Baillie Gifford & Co.
1.16M
3.93%
-96.25K
-7.66%
Mar 31, 2025
State Street Global Advisors (US)
1.01M
3.42%
-54.09K
-5.09%
Mar 31, 2025
Invesco Advisers, Inc.
802.47K
2.72%
+66.89K
+9.09%
Mar 31, 2025
William Blair Investment Management, LLC
692.92K
2.35%
-209.69K
-23.23%
Mar 31, 2025
UBS Asset Management (Switzerland)
659.44K
2.24%
+352.82K
+115.07%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Global X HealthTech ETF
3.07%
Invesco S&P SmallCap Health Care ETF
2.74%
BNY Mellon Innovators ETF
2.18%
Fidelity Digital Health ETF
1.91%
SPDR S&P Health Care Equipment ETF
1.78%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.41%
ETC 6 Meridian Small Cap Equity ETF
0.82%
Invesco S&P SmallCap 600 Pure Growth ETF
0.6%
Harbor Long-Short Equity ETF
0.58%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.56%
View more
Global X HealthTech ETF
Proportion3.07%
Invesco S&P SmallCap Health Care ETF
Proportion2.74%
BNY Mellon Innovators ETF
Proportion2.18%
Fidelity Digital Health ETF
Proportion1.91%
SPDR S&P Health Care Equipment ETF
Proportion1.78%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion1.41%
ETC 6 Meridian Small Cap Equity ETF
Proportion0.82%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion0.6%
Harbor Long-Short Equity ETF
Proportion0.58%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proportion0.56%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI